Antiplatelet Treatment With Cilostazol After Stent Implantation

Heart - United Kingdom
doi 10.1136/hrt.80.4.393
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Antiplatelet Therapy After Drug-Eluting Stent Implantation

Journal of Cardiology
Cardiovascular MedicineCardiology
2015English

Addition of Cilostazol to Conventional Dual Antiplatelet Therapy Reducing the Risk of Cardiac Events and Restenosis After Drug-Eluting Stent Implantation: A Meta-Analysis

Heart
Cardiovascular MedicineCardiology
2012English

Stent Fracture After Sirolimus-Eluting Stent Implantation

Circulation: Cardiovascular Interventions
Cardiovascular MedicineCardiology
2015English

The Effect of Cilostazol on the Angiographic Outcome of Drug-Eluting Coronary Stents Angiographic Analysis of the CILON-T (Influence of CILostazol-Based Triple Antiplatelet Therapy ON Ischemi Complication After Drug-Eluting StenT Implantation) Trial

International Heart Journal
MedicineCardiovascular MedicineCardiology
2017English

Dual Antiplatelet Therapy After Coronary Drug-Eluting Stent Implantation in China: A Large Single Center Study

Catheterization and Cardiovascular Interventions
Nuclear MedicineRadiologyCardiologyCardiovascular MedicineImagingMedicine
2018English

Predictors and Prognosis of Stent Fracture After Sirolimus-Eluting Stent Implantation

Circulation Journal
MedicineCardiovascular MedicineCardiology
2009English

Research and Development of Cilostazol : An Antiplatelet Agent

Yakugaku Zasshi
PharmacologyPharmaceutical Science
2000English

Incomplete Stent Apposition Resolves One Year After Implantation

Cardiovascular Medicine
2017English

One-Year Clinical Outcomes of Patients With Versus Without Acute Coronary Syndrome With 3-Month Duration of Dual Antiplatelet Therapy After Everolimus-Eluting Stent Implantation

PLoS ONE
Multidisciplinary
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy